{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T08:38:59Z","timestamp":1784623139882,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","arthroplastyjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Arthroplasty"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.arth.2024.11.029","type":"journal-article","created":{"date-parts":[[2024,11,17]],"date-time":"2024-11-17T06:39:34Z","timestamp":1731825574000},"page":"1484-1491.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Safety and Efficacy of Aspirin Compared to Enoxaparin Following Total Hip and Total Knee Arthroplasty Among Patients Who Have a History of Venous Thromboembolic Disease"],"prefix":"10.1016","volume":"40","author":[{"given":"Kevin C.","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle M.","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary K.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cory K.","family":"Mayfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie M.","family":"Kistler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay R.","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1293-1702","authenticated-orcid":false,"given":"Nathanael D.","family":"Heckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6 Suppl","key":"10.1016\/j.arth.2024.11.029_bib1","doi-asserted-by":"crossref","first-page":"381S","DOI":"10.1378\/chest.08-0656","article-title":"Prevention of venous thromboembolism: American College of chest physicians evidence-based clinical practice guidelines (8th edition)","volume":"133","author":"Geerts","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.arth.2024.11.029_bib2","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/jama.2022.13416","article-title":"Effect of aspirin vs enoxaparin on symptomatic venous thromboembolism in patients undergoing hip or knee arthroplasty: the CRISTAL randomized trial","volume":"328","author":"Sidhu","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.arth.2024.11.029_bib3","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1302\/0301-620X.94B7.29129","article-title":"The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after knee replacement","volume":"94","author":"Jameson","year":"2012","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.arth.2024.11.029_bib4","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.arth.2009.06.021","article-title":"Does aspirin have a role in venous thromboembolism prophylaxis in total knee arthroplasty patients?","volume":"25","author":"Bozic","year":"2010","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2024.11.029_bib5","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1016\/j.arth.2016.04.004","article-title":"Aspirin as thromboprophylaxis in hip and knee arthroplasty: a systematic review and meta-analysis","volume":"31","author":"An","year":"2016","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2024.11.029_bib6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/01.blo.0000238822.78895.95","article-title":"The benefit of aspirin chemoprophylaxis for thromboembolism after total knee arthroplasty","volume":"452","author":"Lotke","year":"2006","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.arth.2024.11.029_bib7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/01.blo.0000201157.29325.f0","article-title":"Venous thromboembolism is rare with a multimodal prophylaxis protocol after total hip arthroplasty","volume":"444","author":"Della Valle","year":"2006","journal-title":"Clin Orthop Relat Res"},{"issue":"Suppl 1","key":"10.1016\/j.arth.2024.11.029_bib8","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2106\/JBJS.21.01529","article-title":"Recommendations from the ICM-VTE: hip & knee","volume":"104","year":"2022","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2024.11.029_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s43019-022-00166-y","article-title":"What is the best prophylaxis against venous thromboembolism in Asians following total knee arthroplasty? A systematic review and network meta-analysis","volume":"34","author":"Wong","year":"2022","journal-title":"Knee Surg Relat Res"},{"key":"10.1016\/j.arth.2024.11.029_bib10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1712746","article-title":"Aspirin or rivaroxaban for VTE prophylaxis after hip or knee arthroplasty","volume":"378","author":"Anderson","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arth.2024.11.029_bib11","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1161\/CIRCULATIONAHA.111.055731","article-title":"Prevention of venous thromboembolism in total knee and hip replacement","volume":"125","author":"Warwick","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.arth.2024.11.029_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.arth.2016.02.074","article-title":"Aspirin is as effective as and safer than warfarin for patients at higher risk of venous thromboembolism undergoing total joint arthroplasty","volume":"31","author":"Huang","year":"2016","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2024.11.029_bib13","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2106\/JBJS.18.00335","article-title":"Potent anticoagulation does not reduce venous thromboembolism in high-risk patients","volume":"101","author":"Tan","year":"2019","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2024.11.029_bib14","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.11-2404","article-title":"Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"Falck-Ytter","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.arth.2024.11.029_bib15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.arth.2016.02.077","article-title":"Individualized risk model for venous thromboembolism after total joint arthroplasty","volume":"31","author":"Parvizi","year":"2016","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2024.11.029_bib16","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1016\/j.arth.2017.06.041","article-title":"Persistent pulmonary embolism rates following total knee arthroplasty even with prophylactic anticoagulants","volume":"32","author":"Cote","year":"2017","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2024.11.029_bib17","first-page":"187","article-title":"Anticoagulant use and its effect on bleeding and complications in total knee arthroplasty","volume":"78","author":"Radovanovic","year":"2012","journal-title":"Acta Orthop Belg"},{"key":"10.1016\/j.arth.2024.11.029_bib18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.arth.2012.11.003","article-title":"Complications of perioperative warfarin therapy in total knee arthroplasty","volume":"29","author":"Simpson","year":"2014","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2024.11.029_bib19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.arth.2015.07.001","article-title":"Administration of aspirin as a prophylaxis agent against venous thromboembolism results in lower incidence of periprosthetic joint infection","volume":"30","author":"Huang","year":"2015","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2024.11.029_bib20","series-title":"Premier healthcare database: data that informs and performs","year":"2020"},{"key":"10.1016\/j.arth.2024.11.029_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2106\/JBJS.16.00147","article-title":"Low-dose aspirin is effective chemoprophylaxis against clinically important venous thromboembolism following total joint arthroplasty: a preliminary analysis","volume":"99","author":"Parvizi","year":"2017","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2024.11.029_bib22","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.arth.2015.12.007","article-title":"The effectiveness of a risk stratification protocol for thromboembolism prophylaxis after hip and knee arthroplasty","volume":"31","author":"Nam","year":"2016","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2024.11.029_bib23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.arth.2016.01.065","article-title":"Risk-stratified venous thromboembolism prophylaxis after total joint arthroplasty: aspirin and sequential pneumatic compression devices vs aggressive chemoprophylaxis","volume":"31","author":"Odeh","year":"2016","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2024.11.029_bib24","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.arth.2005.04.031","article-title":"Deep vein thrombosis prevention in joint arthroplasties: continuous enhanced circulation therapy vs low molecular weight heparin","volume":"21","author":"Gelfer","year":"2006","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2024.11.029_bib25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.arth.2006.05.017","article-title":"VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty","volume":"21","author":"Westrich","year":"2006","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2024.11.029_bib26","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1302\/0301-620X.99B11.BJJ-2017-0337.R2","article-title":"Aspirin and the prevention of venous thromboembolism following total joint arthroplasty: commonly asked questions","volume":"99-B","author":"Azboy","year":"2017","journal-title":"Bone Joint J"},{"key":"10.1016\/j.arth.2024.11.029_bib27","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.arth.2024.11.029_bib28","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1016\/j.arth.2021.06.001","article-title":"No increased risk of venous thromboembolism in high-risk patients continuing their dose of 75 mg aspirin compared to healthier patients given low-molecular-weight heparin","volume":"36","author":"Hovik","year":"2021","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2024.11.029_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2106\/00004623-200701000-00005","article-title":"Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty","volume":"89","author":"Patel","year":"2007","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2024.11.029_bib30","article-title":"Post hoc power analysis: is it an informative and meaningful analysis?","volume":"32","author":"Zhang","year":"2019","journal-title":"Gen Psychiatr"},{"key":"10.1016\/j.arth.2024.11.029_bib31","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3899\/jrheum.211115","article-title":"Post hoc power calculations: an inappropriate method for interpreting the findings of a research study","volume":"49","author":"Heckman","year":"2022","journal-title":"J Rheumatol"},{"key":"10.1016\/j.arth.2024.11.029_bib32","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-060000","article-title":"Randomised comparative effectiveness trial of Pulmonary Embolism Prevention after hip and kneE Replacement (PEPPER): the PEPPER trial protocol","volume":"12","author":"Pellegrini","year":"2022","journal-title":"BMJ Open"}],"container-title":["The Journal of Arthroplasty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540324012427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540324012427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T22:45:01Z","timestamp":1746830701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883540324012427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0883540324012427"],"URL":"https:\/\/doi.org\/10.1016\/j.arth.2024.11.029","relation":{},"ISSN":["0883-5403"],"issn-type":[{"value":"0883-5403","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and Efficacy of Aspirin Compared to Enoxaparin Following Total Hip and Total Knee Arthroplasty Among Patients Who Have a History of Venous Thromboembolic Disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Arthroplasty","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arth.2024.11.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}